Clorox (NYSE: CLX) reported Q4 EPS of $1.44, $0.07 better than the analyst estimate of $1.37. Revenue for the quarter came in at $1.56 billion versus the consensus estimate of $1.52 billion.

Clorox sees FY2016 EPS of $4.68-$4.83, versus the consensus of $4.84.

For earnings history and earnings-related data on Clorox (CLX) click here.